1. EP-1337: High hypofractionation using beacon transponders in intermediate-risk prostate cancer: first results. (May 2017) Authors: Di Brina, L.; D'agostino, G.; Franzese, C.; Franceschini, D.; Comito, T.; De Rose, F.; Navarria, P.; Tozzi, A.; Iftode, C.; Ascolese, A.; Clerici, E.; Pasini, L.; Benetti, A.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1343: Is stereotactic body radiation therapy a viable option for elderly patients with prostate cancer?. (May 2017) Authors: Franzese, C.; D'agostino, G.; Di Brina, L.; Cozzi, L.; Comito, T.; Franceschini, D.; De Rose, F.; Navarria, P.; Clerici, E.; Ascolese, A.; Tozzi, A.; Iftode, C.; Tomatis, S.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1345: SBRT in low- and intermediate-risk prostate cancer: results of a phase II study. (April 2016) Authors: D'Agostino, G.; Villa, E.; Franzese, C.; Liardo, R.; Reggiori, G.; Navarria, P.; Iftode, C.; De Rose, F.; Franceschini, D.; Tozzi, A.; Comito, T.; Ascolese, A.; Tomatis, S.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1472: Role of SBRT with VMAT-FFF for abdomino-pelvic lymph node metastases in oligometastatic patients. (April 2016) Authors: Franzese, C.; Cozzi, L.; Clerici, E.; Comito, T.; De Rose, F.; D'Agostino, G.; Tozzi, A.; Iftode, C.; Ascolese, A.; Franceschini, D.; Navarria, P.; Liardo, L.; Paganini, L.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0524: Phase II trial on SBRT for Liver Metastases: Long-term outcomes and prognostic factors of survival. (May 2017) Authors: Comito, T.; Franzese, C.; Clerici, E.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.R.; Franceschini, D.; De Rose, F.; Ascolese, A.; Di Brina, L.; Tomatis, S.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0654: Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity. (April 2016) Authors: Navarria, P.; Ascolese, A.; D'agostino, G.; Villa, E.; Clerici, E.; Tozzi, A.; Iftode, C.; De Rose, F.; Liardo, L.; Comito, T.; Franzese, C.; Franceschini, D.; Pessina, F.; Riva, M.; Bello, L.; Reggiori, G.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗